{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-010333","form_type":"8-K","ticker":"HTCR","cik":"0001892322","company_name":"HeartCore Enterprises, Inc.","filed_at":"2024-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.251053+00:00","generated_at":"2026-06-04T15:56:20.794009+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"HeartCore signs 13th Go IPO consulting deal with PharmaBio; $800k fees plus warrant","bullets":["Signed 13th Go IPO consulting agreement with PharmaBio Corporation, second contract in 2024.","Expected compensation: $500,000 in initial fees, $300,000 in success fees, and a warrant for 3% of PharmaBio common stock.","CEO cites recent $9M from warrant sale of a previous Go IPO client; expects 2024 to be strongest year."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-010333","json":"https://secwatch.observer/filing/0001493152-24-010333.json","markdown":"https://secwatch.observer/filing/0001493152-24-010333.md","text":"https://secwatch.observer/filing/0001493152-24-010333.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/0001493152-24-010333-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1892322/000149315224010333/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T15:56:20.794009+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}